Paloma Partners’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-251,900
| Closed | -$219K | – | 2046 |
|
|
2020
Q2 | $219K | Buy |
+251,900
| New | +$219K | ﹤0.01% | 1487 |
|
|
2019
Q1 | – | Sell |
-23,200
| Closed | -$21K | – | 1441 |
|
|
2018
Q4 | $21K | Sell |
23,200
-2,289
| -9% | -$2.07K | ﹤0.01% | 947 |
|
|
2018
Q3 | $52K | Buy |
+25,489
| New | +$52K | ﹤0.01% | 1177 |
|
|
2018
Q2 | – | Sell |
-14,630
| Closed | -$34K | – | 1476 |
|
|
2018
Q1 | $34K | Hold |
14,630
| – | – | ﹤0.01% | 1371 |
|
|
2017
Q4 | $28K | Buy |
+14,630
| New | +$28K | ﹤0.01% | 1221 |
|